129 related articles for article (PubMed ID: 36437707)
21. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
22. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
Guadanhim LR; Gonçalves RG; Bagatin E
Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
[TBL] [Abstract][Full Text] [Related]
23. Effects of isotretinoin on the hair cycle.
İslamoğlu ZGK; Altınyazar HC
J Cosmet Dermatol; 2019 Apr; 18(2):647-651. PubMed ID: 30350907
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin.
El-Hamd MA; El Taieb MA; Ibrahim HM; Aly SS
J Cosmet Dermatol; 2019 Feb; 18(1):16-20. PubMed ID: 29460332
[TBL] [Abstract][Full Text] [Related]
25. Isotretinoin modestly increases platelet count in acne patients.
Karadag AS; Ertugrul DT; Takci Z
J Dermatolog Treat; 2013 Apr; 24(2):139-40. PubMed ID: 21923407
[No Abstract] [Full Text] [Related]
26. Knowledge levels and concerns about oral isotretinoin treatment in the parents of adolescent acne patients.
Kara Polat A; Akin Belli A; Ergun EZ; Manav Bas V; Erdil D; Koku Aksu AE; Gurel MS
Dermatol Ther; 2020 Jul; 33(4):e13669. PubMed ID: 32459383
[TBL] [Abstract][Full Text] [Related]
27. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
28. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
[TBL] [Abstract][Full Text] [Related]
29. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.
El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N
Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
[TBL] [Abstract][Full Text] [Related]
31. A retrospective evaluation of laboratory parameters and hyperuricemia in patients with acne vulgaris under systemic isotretinoin treatment.
Sarac N; Pancar GS; Ozdemir S; Atilla S
J Dermatolog Treat; 2022 Mar; 33(2):1063-1066. PubMed ID: 32705916
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
[TBL] [Abstract][Full Text] [Related]
33. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
[TBL] [Abstract][Full Text] [Related]
34. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
Zane LT; Leyden WA; Marqueling AL; Manos MM
Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
[TBL] [Abstract][Full Text] [Related]
36. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
[TBL] [Abstract][Full Text] [Related]
37. Long-term effect of systemic isotretinoin on female fertility.
Cinar SL; Kartal D; Aksoy H; Cinar E; Aydin T; Öz L; İmamoğlu H; Ferahbas A; Borlu M
Cutan Ocul Toxicol; 2017 Jun; 36(2):132-134. PubMed ID: 27292185
[TBL] [Abstract][Full Text] [Related]
38. A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters.
Murshidi R; Bani Hamad S; Al Refaei A; Shewaikani N; Shaf'ei M; Alshoubaki SN; Haddad TA; Khasawneh T; Fkheideh T; Abdallat M
J Dermatolog Treat; 2024 Dec; 35(1):2301435. PubMed ID: 38186323
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
40. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study.
Karaosmanoğlu N; Mülkoğlu C
BMC Musculoskelet Disord; 2020 Sep; 21(1):631. PubMed ID: 32977793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
